Introduction This Modern Slavery and Human Trafficking Statement is a response to Section 54(1), Part 6 of the Modern Slavery Act 2015 and relates to actions and activities for the financial year ending 30 June 2022. is committed to preventing slavery and human trafficking violations Capital Advisory Ltd (‘the Company’, ‘we’, ‘us’ or ‘our’) in its own operations, its supply chain, and its products. We have zero-tolerance towards slavery and require our supply chain to comply with our values. Organisational Structure Capital Advisory Ltd and has business operations in the United Kingdom. We operate in the medical device market within the healthcare and wellbeing market sector. The nature of our supply chains is as follows: We purchase the product directly from the manufacturer who provides us with a finished product For more information about Policies the Company , please visit our website: www.bcurelaser.co.uk . We operate a number of internal policies to ensure that we are conducting business in an ethical and transparent manner. These include the following: Supplier code of conduct – Each supplier must operate a modern slavery policy. This is checked using an independent inspection company. Procurement policy – We manage the process. Safeguarding policy – All suppliers are vetted by us. We make sure our suppliers are aware of our policies and adhere to the same standards. Due Diligence As part of our efforts to monitor and reduce the risk of slavery and human trafficking occurring in our supply chains, we have adopted the following due diligence procedures: Internal supplier audits. Our due diligence procedures aim to: Identify and action potential risks in our business and supply chains. Monitor potential risks in our business and supply chains Reduce the risk of slavery and human trafficking occurring in our business and supply chains.Risk and Compliance its The Company has evaluated the nature and extent of its exposure to the risk of slavery and human trafficking occurring in UK supply chain through: We Evaluating the slavery and human trafficking risks of each new supplier. do not consider that we operate in a high-risk environment because immediately Our supply chain is based in the UK.. We do not tolerate slavery and human trafficking in our supply chains. Where there is evidence of failure to comply with our policies and procedures by any of our suppliers, we will seek to terminate our relationship with that supplier . Effectiveness trafficking is not taking place in its The Company uses Key Performance Indicators (KPIs) to measure its effectiveness and ensure that slavery and human business and supply chains. These KPIs are as follows: We will contact suppliers to enquire about their modern slavery practices every We will train our staff about modern slavery issues and increase awareness Training Staff Company’s 12 months . within the Company . The Company requires its staff to complete training and ongoing refresher courses on slavery and human trafficking. The training covers: How to identify the signs of slavery and human trafficking. What initial steps should be taken if slavery or human trafficking is suspected. How to escalate potential slavery or human trafficking issues to the relevant parties within the . Company What steps the Company should take if suppliers in its supply chain do not implement anti-slavery policies in high supply chain. risk scenarios, including their removal from the Company’s Next Steps In the next financial year, we intend to take the following steps to tackle slavery and human trafficking by: A supplier meeting will be held in order to give them an opportunity to amend/change their policy The statement was approved by the s_195e0bc1-5216-4186-9d5a-d9d8adef074a_ s_195e0bc1-5216-4186-9d5a-d9d8adef074a_ board of directors Steven Resnick Capital Advisory Ltd , Director d_195e0bc1-5216-4186-9d5a-d9d8adef074a_ d_195e0bc1-5216-4186-9d5a-d9d8adef074a_ . Dat
![](https://bcurelaser.co.uk/wp-content/uploads/78.png)
Prof. Daniel Reis, Orthopedic Surgeon, UK
“I think you will find a lot of patient satisfaction”